Ozempic maker Novo Nordisk (NVO) is asking the U.S. Food and Drug Administration (FDA) to prohibit compounding pharmacies ...

Accessing high quality healthcare without an insurance plan can be nearly impossible. That's why more telehealth providers ...

As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries t ...

Drugs like Wegovy may trim your waistline but not medical costs, according to an analysis of U.S. health insurance claims ...

Over the last year, weight loss medications such as GLP-1s (such as compounded semaglutide, Ozempic or Wegovy) have become ...

Weight loss can be a challenging journey, especially when seeking effective and accessible solutions. The rise in popularity ...

Karan Johar's noticeable weight loss has sparked rumours about his possible use of Ozempic, a diabetes drug known for its ...

Amid ongoing legal battles over coveted GLP-1 therapies, a drug vendor in Washington state is accused of running an ...

Prescription weight loss medications can be a valuable tool in the fight against obesity and overweight when combined with ...

Advocates argue that anti-obesity drugs like Ozempic could help overweight troops, but the services have no uniform policy ...

As obesity rates in the United States soar, insurance companies, including Medicaid and Medicare, are facing financial headwinds to pay for prescription drugs for weight loss. Semaglutide, the generic ...

Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.